Skip Navigation

British Journal of Anaesthesia 2008 101(2):139-140; doi:10.1093/bja/aen192
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Buckenmaier, C. C.
Right arrow Articles by Bleckner, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buckenmaier, C. C., III
Right arrow Articles by Bleckner, L. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2008. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Continuous peripheral nerve blocks and anticoagulation

The first 10% of the full text of this article appears below.

Take calculated risks. That is quite different from being rash.

General George S. Patton (1885–1945)

The increased clinical role and enthusiasm for continuous peripheral nerve block (CPNB) catheters in the anaesthetic and analgesic management of surgical patients is undeniable in modern anaesthetic practice. This is not surprising considering the many benefits regional anaesthesia techniques can provide the surgical patient.1 2 Advances in perioperative venous thromboembolism prevention therapies have paralleled the development of CPNB.3 Unfortunately, these two advances in perioperative patient care have come into conflict because of the risk for haemorrhage, real4 or perceived,5 when CPNB catheters are manipulated in the anticoagulated patient.

In 1993, with the introduction of low molecular weight heparin (LMWH) in the USA, there was . . . [Full Text of this Article]

C. C. Buckenmaier, III* and L. L. Bleckner

Walter Reed Army Medical Center
Uniformed Services University of the Health Sciences
Walter Reed Army Medical Center
6900 Georgia Avenue NW
Washington, DC 20307-5001
USA

* E-mail: chester.buckenmaier@amedd.army.mil


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?